Home NDC 40046-0032 STUDIO SCULPT
Product NDC 40046-0032
11-digit product format 400460032
Labeler code 40046
Product ID 40046-0032_5a09d299-9c80-4b6b-bdeb-4ffe9f290c77
Type HUMAN OTC DRUG
Nonproprietary name OCTINOXATE, TITANIUM DIOXIDE
Dosage form LIQUID
Route TOPICAL
Labeler MAKE UP ART COSMETICS
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2008-09-01
Marketing end 0000-00-00
Substance OCTINOXATE; TITANIUM DIOXIDE
Active strength 7 mL/100mL; mL/100mL
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 40046-0032-1 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 40046-0032-1 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 40046-0032-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 40046-0032-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 40046-0032-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 40046-0032-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 40046-0032-1 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 40046-0032-1 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 40046-0032-1 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 40046-0032-1 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 40046-0032-1 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 40046-0032-1 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 40046-0032-1 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 40046-0032-1 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 40046-0032-1 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 40046-0032-1 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 40046-0032-1 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 40046-0032-1 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 40046-0032-1 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 40046-0032-1 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 40046-0032-1 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 40046-0032-1 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 40046-0032-1 STUDIO SCULPTSPF 15 FOUNDATION 1 in 1 CARTON LIQUID 1 1 40046-0032-2 STUDIO SCULPTSPF 15 FOUNDATION 40 mL in 1 TUBE LIQUID 40 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OCTINOXATE ACTIVE INGREDIENT 4Y5P7MUD51 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 TITANIUM DIOXIDE ACTIVE INGREDIENT 15FIX9V2JP STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 OCTINOXATE ACTIVE MOIETY 4Y5P7MUD51 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 TITANIUM DIOXIDE ACTIVE MOIETY 15FIX9V2JP STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 .ALPHA.-TOCOPHEROL ACETATE, DL- INACTIVE INGREDIENT WR1WPI7EW8 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 ALPHA-TOCOPHEROL, DL- INACTIVE INGREDIENT 7QWA1RIO01 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 BUTYLENE GLYCOL INACTIVE INGREDIENT 3XUS85K0RA STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 CYCLOMETHICONE 5 INACTIVE INGREDIENT 0THT5PCI0R STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 HYALURONATE SODIUM INACTIVE INGREDIENT YSE9PPT4TH STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 ISOSTEARIC ACID INACTIVE INGREDIENT X33R8U0062 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 SHEA BUTTER INACTIVE INGREDIENT K49155WL9Y STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 TAMARINDUS INDICA SEED INACTIVE INGREDIENT 6AHP8A7OML STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 WATER INACTIVE INGREDIENT 059QF0KO0R STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 40046-0032 STUDIO SCULPT SPF 15 FOUNDATION (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [MAKE UP ART COSMETICS] 1 Legacy NDC, 2 package rows 20110301_21045130-f8d5-465d-8628-c6053e95bc55.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 40046-0032-1 40046003201 1 in 1 CARTON Historical 40046-0032-2 40046003202 40 mL in 1 TUBE 40 ml Historical